Opendata, web and dolomites
H2020 projects about "chemotherapy"
The page lists 159 projects related to the topic "chemotherapy".
| # | |||
|---|---|---|---|
| 1 | DiaChemo | Point-of-care microfluidic device for quantification of chemotherapeutic drugs in small body fluid samples by highly selective nanoparticle extraction and liquid crystal detection | 2015 |
| 2 | METASPACE | Bioinformatics for spatial metabolomics | 2015 |
| 3 | MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) | 2015 |
| 4 | GlioVac | Validation of a conceptually new treatment for glioblastoma multiforme with an IP protected small molecule | 2015 |
| 5 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 6 | MEL-PLEX | Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine | 2014 |
| 7 | CancerHetero | Dissection of tumor heterogeneity in vivo | 2015 |
| 8 | NewSpindleForce | A new class of microtubules in the spindle exerting forces on kinetochores | 2015 |
| 9 | MODEST | Mathematical Optimization for clinical DEcision Support and Training | 2015 |
| 10 | BioGuidePCa | Biomarker Guided Prostate Cancer Management | 2014 |
| 11 | Pharmcophore-DOS | Pharmacophore guided diversity-oriented synthesis and its application in discovering inhibitors of protein-protein interactions between RAD51 and BRCA2 | 2015 |
| 12 | STROMAMECH | Targeting stromal cells to modify tumor mechanical microenvironment and optimize drug delivery | 2015 |
| 13 | LiVirIn | 3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction | 2015 |
| 14 | HGSOC | A novel approach into modeling origin and development of ovarian cancer | 2015 |
| 15 | EpiLIVER | Characterization and implications of DNA damage response in liver cancer | 2016 |
| 16 | Diricore | Exploiting vulnerabilities in protein synthesis for cancer diagnosis and therapy | 2015 |
| 17 | MyNano | Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients | 2015 |
| 18 | VIRION | Viruses, Immune stimulation and RNA Interference in Oncology Network | 2015 |
| 19 | ChemoPredict | Predictive in vitro diagnostics test for individualized tailoring of chemotherapy in primary breast cancer | 2015 |
| 20 | EpiTALL | Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation | 2015 |
| 21 | MammaPrint | Improved breast cancer care by innovative diagnostic test MammaPrint | 2015 |
| 22 | platinDx | A test for predicting the efficacy of common platinum drugs enabling personalized chemotherapy for bladder cancer patients. | 2015 |
| 23 | LIFEOMEGA | Innovative highly concentrated Omega 3 food supplement | 2015 |
| 24 | ISPIC | Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome | 2016 |
| 25 | p38Cure | New breast cancer therapies based on available p38 MAPK inhibitors | 2015 |
| 26 | Cancer-Recurrence | Tumor cell death supports recurrence of cancer | 2015 |
| 27 | CerviVax | New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia | 2015 |
| 28 | EPIGEN | EPIGEN: A New Predictive Response Test for Non Small Cells Lung Cancer Treatment | 2015 |
| 29 | COMbAT | Commercialization of a novel tool for designing personalized nOvel MelAnoma Therapies | 2015 |
| 30 | DYNAP | Dynamic Penetrating Peptide Adaptamers | 2016 |
| 31 | ChiLTERN | Children’s Liver Tumour European Research Network | 2016 |
| 32 | H2020MM04 | DC-based immunotherapy to treat Malignant Mesothelioma | 2016 |
| 33 | OncoMasTR | OncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer | 2016 |
| 34 | ICARO | Colloidal Inorganic Nanostructures for Radiotherapy and Chemotherapy | 2016 |
| 35 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 36 | HyGlio | Theranostic Injectable Hydrogel for Glioblastoma | 2016 |
| 37 | MIRNANO | Multifunctional miRNA-targeting nanodevices for pluripotent cancer theranostics | 2017 |
| 38 | THERAGEL | Development of a chemotherapeutic gel for glioblastoma multiforme treatment | 2016 |
| 39 | OPTIM | Optimized drug combinations for effective cancer treatment: a personalised approach. | 2016 |
| 40 | SYNVIA | Synthetic viability of homologous recombination-deficient cancers | 2016 |
| 41 | HEAL-BY-MIRNA | microRNA replacement therapy for mature B cell neoplasias | 2016 |
| 42 | EpiTarget | Epigenome-targeted therapy for cholangiocarcinoma. | 2017 |
| 43 | iCARE | MobIle health-Care system for monitoring toxicity and symptoms in cAncer patients ReceivingdiseasE-oriented therapy | 2016 |
| 44 | pocL-CI | A lab-on-chip platform for blood cell counting and identification at the point-of-care | 2016 |
| 45 | JEM Phase 1 | JEM: The world safest subcutaneous, enclosed, biocompatible implantable device, attached directly to a AV fistula or graft or vein, for chronic disease patients in need of repetitive vascular access | 2016 |
| 46 | Syndivia | Next generation drug conjugates for cancer treatment | 2016 |
| 47 | tagMDR | Identification of Multidrug Resistance for Chemotherapy Guidance in Cancer Using a Lab-on-a-chip Platform | 2016 |
| 48 | NanoSil4Cancer | Smart Multifunctional silica-based Nanoparticles for Targeted Therapy | 2016 |
| 49 | HRMECH | Nucleases in homologous recombination: from basic principles to genome editing | 2016 |
| 50 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 51 | PhotoMedMet | Towards Novel Inert (Photo-)toxic Ru(II) Polypyridyl Complexes | 2016 |
| 52 | EPIPHARM | Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary | 2017 |
| 53 | MULTIFUNSOME | Anti-EGFR Monoclonal Antibody Conjugated Thermoresponsive Liposome for Triple Negative Breast Cancer Thermo-Chemotherapy | 2017 |
| 54 | McHAP | Entrapment of Hypoxic Cancer by Macrophages Loaded with HAP | 2017 |
| 55 | LungCARD | Blood test for clinical therapy guidance of non-small cell lung cancer patients | 2017 |
| 56 | FANCODRUG | Reactivation of the Fanconi anemia-BRCA pathway in cells carrying patient-derived missense mutations: finding a drug to cure Fanconi anemia | 2017 |
| 57 | SpheroPredict | A 3D advanced test for prediction of drug response in secondary liver cancer | 2017 |
| 58 | BGCI | Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology | 2017 |
| 59 | PREDICT | PREcision medicine Drug combination testing In neuroblastoma organoids to guide Clinical Trials | 2017 |
| 60 | TheranOMICS | Integration of high resolution -OMICS datasets towards personalized therapy in bladder cancer | 2017 |
| 61 | BCSC-ST | Breast cancer stem-like cells specific vulnerabilities: focus in HER2 over-expression and protein glycosylation | 2017 |
| 62 | LIFEOMEGA | Innovative highly concentrated Omega-3 Specialized Nutrition Product | 2017 |
| 63 | PhoRAu | Photochemistry and radiolabelling of gold(III) anticancer prodrugs | 2018 |
| 64 | PROM | Pregnancy and Reproduction Organ-on-a-chip Models | 2017 |
| 65 | MSCFate | Fate of mammary stem cells during tumorigenesis and clinical implications | 2017 |
| 66 | APACHE | Atmospheric Pressure plAsma meets biomaterials for bone Cancer HEaling | 2017 |
| 67 | PHRD | The development of Personalised Host Response Diagnostic kit | 2017 |
| 68 | META-DORM | Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions | 2018 |
| 69 | NGN-PET | Modelling Neuron-Glia Networks into a drug discovery platform for Pain Efficacious Treatments - Sofia ref.: 116072 | 2017 |
| 70 | DrugComb | Informatics approaches for the rational selection of personalized cancer drug combinations | 2017 |
| 71 | MetaboMARKER | A metabolism-based prognostic biomarker for prostate cancer | 2017 |
| 72 | OVO-GROWTH | Oogenesis spotlighted: making mature human oocytes | 2017 |
| 73 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
| 74 | onCOMBINE | Towards evidence-based combinations of approved and novel cancer drugs | 2017 |
| 75 | HypoRuLight | Hypoxic Tumour Models for Photoactivatable Ruthenium-based Chemotherapy | 2017 |
| 76 | TREAT-NPM1-AML | Improving therapy of NPM1-mutated AML | 2017 |
| 77 | CfC | Carrier for Cure: tailored combination drug delivery solutions for oncology | 2017 |
| 78 | NEOSETAC | New Selenium-based Targeted Nanocapsules to treat Breast Cancer | 2018 |
| 79 | safenolaTiCancerDrug | Highly and Widely Effective, Water Stable, and Non Toxic Titanium-Phenolato-based Anticancer Chemotherapy | 2017 |
| 80 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
| 81 | CylcoRu4PACT | Cyclometallated ruthenium complexes for photo-activated chemotherapy | 2018 |
| 82 | COLOSSUS | Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions | 2018 |
| 83 | LIMA | Liquid biopsies and Imaging for improved cancer care | 2018 |
| 84 | PLASREVOLUTION | Understanding the evolution of plasmid-mediated antibiotic resistance in real life scenarios | 2018 |
| 85 | AltCheM | In vivo functional screens to decipher mechanisms of stochastically- and mutationally-induced chemoresistance in Acute Myeloid Leukemia | 2018 |
| 86 | GlycoEdit | New Chemical Tools for Precision Glycotherapy | 2017 |
| 87 | CANCER | Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life | 2018 |
| 88 | ITHACA | Immuno-targeting of human AML quiescent cells by a novel phage display approach. | 2018 |
| 89 | OmnImmune | Manufacturing and testing of an allogeneic gamma delta T cell therapy for the treatment of cancer | 2017 |
| 90 | MetaRegulation | Metabolic regulation of metastatic growth | 2018 |
| 91 | iaFRET | An amplified signal imaging software for prognosis of cancer enabling the evaluation of clinicalefficiency of personalised cancer treatments to an unprecedented level. | 2018 |
| 92 | NIRCOThera | Spatiotemporal, near-infrared light controlled carbon monoxide delivery for cancer immunotherapy | 2018 |
| 93 | VALSL | Valorisation of splice-switching oligonucleotides for lung cancer therapy | 2018 |
| 94 | SenPET | Innovative cancer management: First in human senescence imaging | 2018 |
| 95 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 96 | SPeNTa-Brain | Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours | 2019 |
| 97 | MITIG | Addressing MITochondrial Import by Glioblastoma cells to rewire respiratory metabolism | 2019 |
| 98 | MTOAC | Multi-compartmental Tumor-on-a-Chip | 2018 |
| 99 | InTheMLLrBALL | Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia | 2018 |
| 100 | rDNAstress | Novel insights into DNA damage and stress responses in the nucleolus: Mechanisms and relevance for genomic (in)stability and cancer | 2019 |
| 101 | MAGNET-CELLPATCH | Multimodal magnetic cellular-patches with synergistic effects for high performance theranostics | 2019 |
| 102 | PORTAL | Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX) | 2018 |
| 103 | GLIOGUIDE | Commercialising a novel glioblastoma targeted therapy and a companion diagnostic compound | 2018 |
| 104 | pBioStrat-for-PDA | Use of PAP as a biomarker and stratifier of pancreatic cancer to improve patient management | 2018 |
| 105 | HyperCollar3D | Improving the Treatment of Head and Neck Cancer without Additional Side Effects | 2018 |
| 106 | SMARTRIOX | Disruptive targeted drug delivery system via synergistic combination of intelligent DNA molecular machines and gated mesoporous nanoparticles | 2018 |
| 107 | ExitAplasia | Reg-X310: new disruptive medicine for faster exit from aplasia afetr agressive chemotherapy of hematologic malignancies | 2018 |
| 108 | ONCORED | An unrivalled medical device based on red- light photo biomodulation to prevent, improve and remove oral mucositis and dermatitis chemo radio induced as a side effect of cancer treatment | 2018 |
| 109 | SenolT | Fast and effective diagnostic test for the early detection of residual tumours to prevent cancer recurrence | 2018 |
| 110 | THERMONANO | Nanoassemblies for the subcutaneous self-administration of anticancer drugs | 2018 |
| 111 | Simecos | A New Adjuvant Nutraceutical from the North Atlantic Ocean for Breast, Lung and Pancreatic Cancer Patients | 2018 |
| 112 | LapIt | Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells | 2019 |
| 113 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
| 114 | p38_InTh | Innovative therapeutic tools to ameliorate chemotherapy-induced cardiotoxicity | 2018 |
| 115 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 116 | LUMAX | Innovative Laser and Fiber System for Non-Toxic, Efficient and Cost-Effective Treatment of Cancer | 2018 |
| 117 | TCRabX | Structural basis for the therapeutic efficiency of optimal-affinity T cell receptors | 2019 |
| 118 | MP-101 | a novel drug for prevention and treatment peripheral neuropathy symptoms | 2019 |
| 119 | CancerFingerPrints | Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis | 2019 |
| 120 | VESSEL CO-COPTION | Vessel co-option and radioresistance in glioblastoma | 2019 |
| 121 | RESIST3D | Targeting drug resistance in ovarian cancer through large-scale drug-response profiling in physiologically relevant cancer organoids | 2020 |
| 122 | REAP | Repair of DNA lesions induced by platinum drugs | 2019 |
| 123 | THERMOGUIDE | Optimizing delivery and effectiveness of chemotherapy in breast cancer patients using thermotherapy under image-guidance | 2019 |
| 124 | MHT-ImmunoEnhancer | Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment | 2019 |
| 125 | Inflapoptosis | Gasdermin D is a novel effector in the extrinsic apoptosis pathway | 2019 |
| 126 | TorsionAtLamina | TWISTING THE BOUNDARIES: ROLE OF TOPOISOMERASE 1 AT THE NUCLEAR LAMINA | 2020 |
| 127 | PRINT-CHEMO | To develop 3D bioPRINTed osteoinductive constructs that deliver CHEMOtherapeutics within large bone defects that are surgically created when removing bone tumours. | 2019 |
| 128 | PhotoStem | Photoswitching molecules for the spatiotemporal control of cancer stem cells with light | 2019 |
| 129 | ICE-METs | Interstitium-on-a-chip to explore its role in cancer metastasis | 2019 |
| 130 | FUNTRICAN | Functional analysis of thyroid hormone nuclear receptors TRs in human Intestinal Cancer stem cells | 2019 |
| 131 | SUPERBRAIN | Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy | 2020 |
| 132 | MIRACLE | Metabolic Imaging with RF Antennas to predict Chemotherapy Efficacy | 2019 |
| 133 | CB-103 | First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers | 2019 |
| 134 | TARGLIO | Improved glioblastoma treatment through targeted, local drug delivery | 2019 |
| 135 | INTRA | The first ultrasound-compatible cranial prosthesis enabling diagnostic and therapeutic use of ultrasound in brain pathologies | 2019 |
| 136 | VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | 2019 |
| 137 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
| 138 | Promitil | Promitil® - a new ‘smart’ nanomedicine for cancer chemo-radiotherapy. | 2019 |
| 139 | ABOLED | Commercial feasibility of an anti-bacterial treatment | 2019 |
| 140 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 141 | SECRET | Exploitation of the SECRETory pathway for cancer therapy to address European research | 2019 |
| 142 | NeutroCure | Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. | 2020 |
| 143 | HIL PT System | A revolutionary, cost effective, ultra-compact proton therapy system for cancer treatment | 2019 |
| 144 | TroyCAN | Redefining the esophageal stem cell niche – towards targeting of squamous cell carcinoma | 2020 |
| 145 | ChronicPain | New Target and Drug Candidates for Alleviating Chronic Pain | 2019 |
| 146 | ONCORELIEF | A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment. | 2020 |
| 147 | ImOPac | GemciTest: An innovative In Vitro Diagnostic for the decision-making process of pancreatic cancer treatment | 2019 |
| 148 | Lottare GBM | LOcalized Targeted Therapy to Avoid REcurrent GlioBlastoma Multiforme | 2019 |
| 149 | HyperCube | HyperCube: Gram scale production of ferrite nanocubes and thermo-responsive polymer coated nanocubes for medical applications and further exploitation in other hyperthermia fields | 2020 |
| 150 | Ru4EYE | Ruthenium-based photoactivated chemotherapy against eye cancer | 2020 |
| 151 | ClickandTreatCancer | Ligand Directed NIR-based Theranostic Prodrugs for Prostate Cancer | 2020 |
| 152 | Hemstem | Targeting leukaemia by modulating hematopoietic stem cell competitiveness | 2020 |
| 153 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
| 154 | NetriCan | Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. | 2020 |
| 155 | NANOCRISPR | NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS | 2021 |
| 156 | MAMBO | Magnetic swArms for liver chemoeMBOlization | 2020 |
| 157 | PDASwITch | Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer | 2020 |
| 158 | HypoCyclo | Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions | 2020 |
| 159 | SecondCANCERinKIDS | What causes therapy-related malignancies in childhood cancer survivors? Dissecting the etiology of second cancers | 2020 |